Proton pump inhibitors are associated with increased risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation
SIR ePoster library. Lewis D. 03/17/18; 209015; 627
Douglas Lewis
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}